Ko HH - Search Results

1

Downregulation of PAX1 in OSCC Enhances Stemness and Immunosuppression via IFIT1 and PD-L1 Pathways.

Ko HH, Peng HH, Chou HE, Hou HH, Liu WW, Kuo MY, Lee AY, Kao HF, Lin HY, Chang YC, Kuo WT, Cheng SJ. Ko HH, et al. Oral Dis. 2025 Jan 2. doi: 10.1111/odi.15225. Online ahead of print. Oral Dis. 2025. PMID: 39748231

2

β-glucan therapy converts the inhibition of myeloid-derived suppressor cells in oral cancer patients.

Lo YW, Lee AY, Liu YC, Ko HH, Peng HH, Lee HC, Pan PY, Chiang CP, Cheng SJ. Lo YW, et al. Among authors: ko hh. Oral Dis. 2022 Sep;28(6):1484-1495. doi: 10.1111/odi.13827. Epub 2021 Mar 13. Oral Dis. 2022. PMID: 33655573

3

Lysyl oxidase-like 2 promotes stemness and enhances antitumor effects of gefitinib in head and neck cancer via IFIT1 and IFIT3.

Lu YJ, Deng YT, Ko HH, Peng HH, Lee HC, Kuo MY, Cheng SJ. Lu YJ, et al. Among authors: ko hh. Cancer Sci. 2023 Oct;114(10):3957-3971. doi: 10.1111/cas.15912. Epub 2023 Jul 26. Cancer Sci. 2023. PMID: 37496288 Free PMC article.

4

Metastasis and immunosuppression promoted by mtDNA and PD-L1 in extracellular vesicles are reversed by WGP β-glucan in oral squamous cell carcinoma.

Ko HH, Peng HH, Cheng AN, Chou HE, Hou HH, Kuo WT, Liu WW, Kuo MY, Lee AY, Cheng SJ. Ko HH, et al. Cancer Sci. 2023 Oct;114(10):3857-3872. doi: 10.1111/cas.15919. Epub 2023 Jul 31. Cancer Sci. 2023. PMID: 37525561 Free PMC article.

5

Hypermethylated ZNF582 and PAX1 genes in oral scrapings collected from cancer-adjacent normal oral mucosal sites are associated with aggressive progression and poor prognosis of oral cancer.

Cheng SJ, Chang CF, Ko HH, Liu YC, Peng HH, Wang HJ, Lin HS, Chiang CP. Cheng SJ, et al. Among authors: ko hh. Oral Oncol. 2017 Dec;75:169-177. doi: 10.1016/j.oraloncology.2017.11.013. Epub 2017 Nov 17. Oral Oncol. 2017. PMID: 29224816

6

Increased salivary AKR1B10 level: Association with progression and poor prognosis of oral squamous cell carcinoma.

Ko HH, Peng HH, Cheng SJ, Kuo MY. Ko HH, et al. Head Neck. 2018 Dec;40(12):2642-2647. doi: 10.1002/hed.25370. Epub 2018 Nov 14. Head Neck. 2018. PMID: 30430672

7

Upregulated NPM1 is an independent biomarker to predict progression and prognosis of oral squamous cell carcinomas in Taiwan.

Peng HH, Ko HH, Chi NC, Wang YP, Lee HC, Pan PY, Kuo MY, Cheng SJ. Peng HH, et al. Among authors: ko hh. Head Neck. 2020 Jan;42(1):5-13. doi: 10.1002/hed.25971. Epub 2019 Oct 1. Head Neck. 2020. PMID: 31571325

8

ZNF582 hypermethylation as a prognostic biomarker for malignant transformation of oral lesions.

Juan YC, Su YF, Bai CH, Fan YC, Kuo TT, Ko HH, Peng HH, Chiang CP, Fwu CW, Cheng SJ. Juan YC, et al. Among authors: ko hh. Oral Dis. 2023 Mar;29(2):505-514. doi: 10.1111/odi.13946. Epub 2021 Jul 1. Oral Dis. 2023. PMID: 34145953

9

Fibroblast growth factor 5 expression predicts the progression of oral squamous cell carcinoma.

Shie WY, Cheng SJ, Chen KC, Tang CC, Peng HH, Ko HH, Hou HH, Elizabeth Chou HY. Shie WY, et al. Among authors: ko hh. J Formos Med Assoc. 2024 Mar;123(3):390-399. doi: 10.1016/j.jfma.2023.08.020. Epub 2023 Sep 11. J Formos Med Assoc. 2024. PMID: 37704482 Free article.

10

Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma.

Ko HH, Cheng SL, Lee JJ, Chen HM, Kuo MY, Cheng SJ. Ko HH, et al. Head Neck. 2017 Jul;39(7):1327-1332. doi: 10.1002/hed.24759. Epub 2017 Mar 16. Head Neck. 2017. PMID: 28301069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters